Vascular Dementia
📧 Sign up to get email alerts when something new happens for Vascular Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Computational Tools for Early Diagnosis of Memory Disorders
The trial update reports completion of a University of Eastern Finland–led study evaluating computational tools for early diagnosis of memor…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Rivastigmine Capsules in Patients With Probable Vascular Dementia [Phase 3]
A Phase 3 study evaluating rivastigmine capsules for probable vascular dementia has completed.
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
This is a completed clinical trial update evaluating the comparative effectiveness of treatments for mild cognitive impairment and dementia …
-
CLINICAL_TRIALS research · 2016-05-02Clinical Trial Update: Symptomatic Treatment of Vascular Cognitive Impairment [Phase 2, Phase 3]
A clinical trial update describing a Phase 2/Phase 3 study of symptomatic treatment for vascular cognitive impairment, with current status u…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: A Longitudinal Multidimensional Population Study on Brain Aging
This entry reports the completion of a longitudinal population study on brain aging sponsored by Fondazione Golgi Cenci. It focuses on demen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) [Phase 4]
Phase 4 study assessing low-dose opiate therapy to relieve discomfort in patients with Alzheimer's disease and other forms of dementia has c…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions [Phase 4]
Phase 4 clinical trial comparing cilostazol to aspirin for vascular dementia in post-stroke patients with white matter lesions has completed…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging [NA]
Status update on a trial evaluating MRI and PET imaging for early diagnosis of Alzheimer-like dementia; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Delta-THC in Dementia [Phase 2]
A Phase 2 trial evaluating delta-THC for behavioral disturbances and pain in dementia patients has completed. The study included Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
This completed clinical trial compares long-term use of galantamine versus unspecified memory-enhancing drugs in patients with Alzheimer's d…
-
CLINICAL_TRIALS research · 2014-05-08Clinical Trial Update: The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule [Phase 2]
A Phase 2 clinical trial of SaiLuoTong Capsule for vascular dementia is being conducted by Shineway Pharmaceutical, with no results reported…
-
CLINICAL_TRIALS research · 2013-12-23Clinical Trial Update: Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study
This clinical trial update describes a study using dynamic contrast-enhanced MRI to investigate blood-brain barrier leakage in dementia. The…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
The NAC-003 P.L.U.S. Program clinical trial sponsored by Pamlab, Inc. has completed, evaluating effects in mild cognitive impairment, early …
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients n…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia [Phase 4]
Phase 4 trial evaluating the efficacy and safety of donepezil hydrochloride (Aricept) for vascular dementia has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency) [Phase 2]
Phase 2 trial of STA-1 Capsule in vascular dementia has completed. No results are reported in the update.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia [Phase 3]
This document reports a completed Phase 3 trial evaluating rivastigmine capsules for probable vascular dementia. It focuses on efficacy and …
-
CLINICAL_TRIALS research · 2011-11-08Clinical Trial Update: Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity [Phase 2]
A Phase 2 clinical trial studied udenafil (Zydena) for its effects on cerebral blood flow and peripheral blood viscosity in vascular dementi…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia [Phase 3]
This update reports the completion of a Phase 3 placebo-controlled trial evaluating galantamine for vascular dementia.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Phase 3]
This Phase 3 trial evaluated the safety and effectiveness of galantamine versus placebo in patients with vascular dementia or mixed dementia…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease [Phase 3]
A Phase 3 study evaluating donepezil hydrochloride (E2020) for dementia associated with cerebrovascular disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Non-Interventional Study With Aricept® Evess
Pfizer conducted a completed non-interventional study of Aricept Evess (donepezil transdermal patch) for Alzheimer's disease and vascular de…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
A Phase 3 trial evaluated the effectiveness and safety of risperidone for behavioral disturbances in dementia patients and has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
Phase 3 randomized trial comparing risperidone to placebo for behavioral disturbances in dementia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
This document reports results from a Phase 3 trial evaluating the effectiveness and safety of risperidone for behavioral disturbances in pat…